| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -350,0 € | +53.5% | -753,0 € | -4.4% | -721,0 € | +74.1% | -2,8 k € | -263.9% | -764,0 € | -85.0% | -413,0 € | +45.2% | -754,0 € | -29.1% | -584,0 € | +14.7% | -685,0 € | +70.8% | -2,3 k € | -26.7% | -1,9 k € | -9.1% | -1,7 k € | -5.6% | -1,6 k € | +62.1% | -4,2 k € | -20.0% | -3,5 k € | +6.1% | -3,8 k € | +13.8% | -4,4 k € | +6.0% | -4,6 k € | +1.0% | -4,7 k € | |
| EBITDA | -750,0 € | +0.4% | -753,0 € | -4.4% | -721,0 € | +74.1% | -2,8 k € | -263.9% | -764,0 € | -85.0% | -413,0 € | +45.2% | -754,0 € | -29.1% | -584,0 € | +14.7% | -685,0 € | +70.8% | -2,3 k € | -6.6% | -2,2 k € | +14.2% | -2,6 k € | -3.6% | -2,5 k € | +51.5% | -5,1 k € | -12.8% | -4,5 k € | +4.8% | -4,8 k € | +11.2% | -5,4 k € | +4.8% | -5,6 k € | -15.9% | -4,9 k € | |
| Operating profit | -750,0 € | +0.4% | -753,0 € | -4.4% | -721,0 € | +74.1% | -2,8 k € | -263.9% | -764,0 € | -85.0% | -413,0 € | +45.2% | -754,0 € | -29.1% | -584,0 € | +14.7% | -685,0 € | +70.8% | -2,3 k € | -6.6% | -2,2 k € | +14.2% | -2,6 k € | -3.6% | -2,5 k € | +51.5% | -5,1 k € | -12.8% | -4,5 k € | +4.8% | -4,8 k € | +11.2% | -5,4 k € | +18.5% | -6,6 k € | -13.3% | -5,8 k € | |
| Profit/loss | 201,0 € | -47.4% | 382,0 € | +144.4% | -861,0 € | +71.3% | -3,0 k € | -236.0% | -894,0 € | -65.6% | -540,0 € | +7.1% | -581,0 € | -117.6% | -267,0 € | -16.6% | -229,0 € | +89.8% | -2,2 k € | -535.2% | -352,0 € | -118.9% | 1,9 k € | -46.8% | 3,5 k € | -53.4% | 7,5 k € | +334.5% | 1,7 k € | -81.9% | 9,6 k € | -55.3% | 21,4 k € | +153.6% | 8,5 k € | -10.2% | 9,4 k € | |
| Equity | 560,6 k € | +0.0% | 560,4 k € | +0.1% | 560,0 k € | -0.2% | 560,9 k € | -0.5% | 563,9 k € | -0.2% | 564,8 k € | -0.1% | 565,3 k € | -0.1% | 565,9 k € | -0.0% | 566,1 k € | -0.0% | 566,4 k € | -0.4% | 568,6 k € | -0.1% | 569,0 k € | +0.3% | 567,1 k € | +0.6% | 563,6 k € | +1.4% | 556,1 k € | +0.3% | 554,4 k € | +1.8% | 544,8 k € | +4.1% | 523,3 k € | +1.6% | 514,9 k € | |
| Total assets | 561,0 k € | +0.1% | 560,4 k € | +0.1% | 560,0 k € | -0.2% | 560,9 k € | -0.5% | 563,9 k € | -0.2% | 564,8 k € | -0.1% | 565,3 k € | -0.2% | 566,2 k € | -2.1% | 578,5 k € | +2.1% | 566,6 k € | -0.3% | 568,6 k € | -0.1% | 569,2 k € | +0.2% | 567,9 k € | -21.2% | 720,3 k € | +1.2% | 711,6 k € | +0.2% | 709,9 k € | +1.4% | 700,2 k € | +3.6% | 675,8 k € | +1.3% | 667,4 k € | |
| Cash | 170,4 k € | +0.5% | 169,6 k € | -0.0% | 169,6 k € | -0.5% | 170,5 k € | -1.7% | 173,5 k € | -0.5% | 174,4 k € | -0.3% | 174,9 k € | -0.5% | 175,7 k € | -6.6% | 188,1 k € | -61.4% | 486,6 k € | -14.2% | 567,0 k € | — | 296,0 € | -95.5% | 6,6 k € | -37.4% | 10,5 k € | +334.1% | 2,4 k € | — | 25,8 k € | +57.1% | 16,4 k € | |||||
| Debts | 400,0 € | — | — | — | — | — | — | 272,0 € | -97.8% | 12,3 k € | +4425.4% | 272,0 € | — | 272,0 € | -66.7% | 817,0 € | -99.5% | 156,7 k € | +0.8% | 155,5 k € | 0.0% | 155,5 k € | +0.0% | 155,5 k € | +1.9% | 152,5 k € | 0.0% | 152,5 k € | ||||||||||
Public limited company · Frameries · incorporated on 09/07/2002
Public limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
FELIX PHARMA is a Public limited company incorporated in 2002. Its registered office is in Frameries.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette